November 2010 Archives

November 24, 2010

Preeclampsia Significantly Reduced with Blood Thinners (11.24.10)

Utilizing blood thinners, such as heparin and aspirin, during pregnancy results in significant reduction in preeclampsia particularly in women with a history of preeclampsia, according to a recent study. Additional, larger studies are still necessary before fully understanding the efficacy and safety of blood thinners during pregnancy.

ASN: Blood Thinners Squelch Early Preeclampsia

November 24, 2010

Cinnamon Effective in Controlling Blood Sugar (11.24.10)

A number of studies have shown that cinnamon is effective in helping diabetics control their blood sugar (glucose). In addition, recent study data show that it can also reduce body fat and improve lean muscle mass. Cinnamon's Medicinal Properties

November 19, 2010

Propoxyphene (Darvon/Darvocet) Removed from Market Due to Risk of Serious Cardiac Toxicity

Xanodyne Pharmaceuticals will remove propoxyphene from the U.S. market due to serious toxicity to the heart.
For further information, go to: Propoxyphene: Withdrawal - Risk of Cardiac Toxicity

November 19, 2010

Elevated D-Dimer (fibrin degradation product that is present after a blood clot degraded) Associated with Increased Risk of Atrial Fibrillation Stroke (11.19.10)

New data show that an elevated D-Dimer concentration are an independent predictor of increased stroke or emboli risks. AHA: D-Dimer Predicts Afib Stroke Risk

November 19, 2010

Controlling Hypertension with Electrical Stimulation of Renal Nerves (11.18.10)

Adrian has developed the Symplicity Catheter System that sends electrical current to renal nerves and results in lower blood pressure. The system is being utilized in patients who are unable to control their hypertension with prescription drugs. A one-time procedure that may provide a lasting benefit.

November 17, 2010

Night time Deliveries at Increased Risk of Neonatal Encephalopathy (11.17.10)

According to a recent study, babies delivered during the night were at an increased risk of encephalopathy, asphyxia and seizures. Nighttime delivery and risk of neonatal encephalopathy

November 17, 2010

New CETP Inhibitor (Anacetrapib) Shows Dramatic Cholesterol Benefits (11.17.10)

Merck's new cholesteryl ester transfer protein (CETP) inhibitor reduced LDL cholesterol levels by 36% while increase good cholesterol (HDL) levels by 138%. Additionally, the drug appears to be without any significant adverse effects, like its predecessor Torcetrapib.
http://www.theheart.org/article/1151979.do

November 17, 2010

Second Trimester Amniocentesis for Pregnant Women 35 and Older Result in Increased Risk of Fetal Demise (11.17.10)

New study data show that women 35 and older who undergo a second trimester amniocentesis are more than twice as likely to experience fetal demise/loss than those who undergo an amniocentesis before their second trimester. Fetal loss associated with second trimester amniocentesis

November 15, 2010

Infusion Pump Recall: Sigma Spectrum Infusion Pump Model 35700 (11.15.10)

FDA has recalled the SIGMA Spectrum Infusion Pump Model 35700 because they nits may produce altered flow conditions, such as back flow, over-infusion, including free flow without producing an alarm.
For additional information, go to: Sigma Spectrum Infusion Pump Model 35700: Class 1 Recall: Risk of Over-Infusion

November 12, 2010

Label Changes for 34 Prescription Drugs in 2010 (11.12.10)

The FDA has published a comprehensive list of this year's (2010) labeling changes for thirty-four prescription drugs. Go to October 2010

November 8, 2010

MRI Accurate In Diagnosing Acute Abdominal Pain after Indeterminate Ultrasound (11.8.10)

A recent study showed 100% accuracy in diagnosing the cause of acute abdominal/pelvic pain for pregnant women whose ultrasounds were indeterminate.

Acute abdominal and pelvic pain in pregnancy: MR imaging as a valuable adjunct to ultrasound?

November 8, 2010

Brachial Plexus Maneuvers Effective for Reducing Brachial Nerve Stretch (11.5.10)

Utilizing a computer model of shoulder dystocia, researchers determined that the current methods for delivering infants encountering shoulder dystocia is substantially more effective in reducing pressure and nerve stretching than dorsal lithotomy position (i.e., legs in stirrups and buttocks at edge of table).
Data show that delivering the posterior arm alone resulted in greater than 70% decrease in anterior nerve stretch and even greater decrease in delivery force.

Am J Obstet Gynecol. 2010 Oct;203(4):339.e1-5. Epub 2010 Jun 26.

PMID: 20580342 [PubMed - indexed for MEDLINE]

November 5, 2010

Antiepileptic polytherapy (more than one prescription drug) During Pregnancy Associated with Intellectual Deficits (11.5.10)

A recent study indicates that children whose mothers took more than one antiepileptic medication (polytherapy) during pregnancy have approximately a three-fold increased risk of intellectual deficits during their teenage years. Of interest, children of pregnant mothers who took on one antiepileptic medication (monotherapy) during pregnancy did not exhibit any intellectual deficits.


Primary source: Epilepsia
Source reference: Epilepsia

November 3, 2010

Hospital of the Future: El Camino Hospital, Silicon Valley, CA (11.3.10)

El Camino Hospital has employed some rather impressive technologies to advance patient care and safety. To learn more about El Camino Hospital, go to: El Camino Hospital

November 3, 2010

Excessive Daytime Sleepiness For Elderly Could Signal Increased Risk of Cardiovascular Disease (11.2.10)

A recent study by the European Society of Cardiology shows that elderly patients reporting excessive sleepiness during the day had a 49% increased risk of dying from cardiovascular disease, myocardial infarction (heart attack) or heart failure.


Excessive Daytime Sleepiness is an independent Risk Indicator for Cardiovascular Mortality in Community Dwelling Elderly. The Three Cities Study. JP Empana, Y Dauviliers, JF Dartigues et al. Stroke 2009: 40:00-00. 1-6

Source: ESC Press Office
European Society of Cardiology

November 1, 2010

Medtronic's Octopus Nuvo Tissue Stabilizer May Fracture Causing Patient Harm (11.1.10)

Two reports of fragments from the tissue stabilizer falling into patients' chest cavity have been received by Medtronic. It is recommended that Octopus Nuvo Tissue Stabilizer devices be returned to Medtronic and not utilized on patients.
To report issues with this device:
• Complete and submit the report Online: www.fda.gov/MedWatch/report.htm
Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
For additional information, go to: Octopus Nuvo Tissue Stabilizer: Recall - Potential for Device Fracture